AbbVie Gastroenterology Pipeline to be Featured at the 16th Congress of European Crohn's and Colitis Organisation Biotech Investing
Kite Announces Yescarta® CAR T-cell Therapy Improved Event-Free Survival by 60% Over Chemotherapy Plus Stem Cell Transplant in Second-Line Relapsed or Refractory Large B-cell Lymphoma Biotech Investing
Hollister Biosciences Inc. Announces Launch of Pre-Roll Production and Distribution in Arizona Psychedelics Investing
Awakn Life Sciences Files Patent Applications in U.S. for AWKN001 and AWKN002, Two Next-Generation New Chemical Entities [NCES] to Treat a Broad Range of Addiction Indications Psychedelics Investing
COMPASS Pathways completes COMP360 psilocybin therapy administration for 216 patients in large-scale phase IIb psilocybin therapy trial for treatment-resistant depression Psychedelics Investing
Seelos Therapeutics Added to the Russell 2000®, Russell 3000® and Russell Microcap® Indexes Psychedelics Investing
Late-Breaking Data Demonstrate Abbott's FreeStyle® Libre System Supports Health Equity for Millions of Americans Living with Diabetes Medical Device Investing
